• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS DE MEXICO PRECISE PRO RX US CAROTID SYST; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS DE MEXICO PRECISE PRO RX US CAROTID SYST; STENT, CAROTID Back to Search Results
Catalog Number PC1040RXC
Device Problem Detachment Of Device Component (1104)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/26/2017
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing documentation associated with this lot (17666761) presented no issues during the manufacturing process that can be related to the reported event.  additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, during a carotid stenting procedure the precise pro rx catheter split apart while trying to position the stent device in the tranverse venous sinus.The entire device was able to be removed and another catheter was used.There was no reported patient injury.The device was stored and handled per the ifu.There were no anomalies noted during or after the device was prepped.There were no kinks or other damages noted prior to inserting the product into the patient.The device was not used for treatment of a chronic total occlusion.The device was easily removed from the patient intact (in one piece).Then, a new precise stent was reinserted and deployed with no difficulty.The procedure was finished successfully.
 
Manufacturer Narrative
During a carotid stenting procedure, the precise pro rx catheter split apart while trying to position the stent in the transverse venous sinus.The entire device was able to be removed and another catheter was used.There was no reported patient injury.The device was stored and handled per the ifu.There were no anomalies noted during or after the device was prepped.There were no kinks or other damages noted prior to inserting the product into the patient.The device was not used for treatment of a chronic total occlusion.The device was easily removed from the patient intact (in one piece).Then, a new precise stent was reinserted and deployed with no difficulty.The procedure was finished successfully.One non-sterile unit of a precise pro rx us carotid syst was received for analysis coiled inside a plastic bag.Per visual analysis, the outer member was received separated at 20 cm from distal end.The stent was received inside the unit (not deployed).Sem analysis was performed to the separation on the sheath outer member with the following results: the separated sections of precise pro rx outer and inner member presented elongations and frayed edges.These characteristics present are evident of an application of a tension force that induced the separation.A device history record (dhr) review of lot (17666761) revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿stent delivery system (sds)-ses- separated - in patient¿ was confirmed due to the separated condition of unit received.The exact cause of the separated condition of unit could not be conclusively determined neither by sem nor by product analysis.The cordis precise pro rx nitinol stent system is indicated for use in patients with atherosclerotic disease of the carotid artery(ies) who are at increased risk for surgery.Based on the information available for review, vessel characteristics (slight tortuosity and a rate of stenosis of at least 90%) or procedural factors may have contributed to the event as evidenced by damage noted on the outer member during analysis.According to the instructions for use ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.¿ neither the device history record (dhr) review nor the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, no corrective/preventive action will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX US CAROTID SYST
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS DE MEXICO
circuito int nte 1820
juarez 32575
MX  32575
Manufacturer (Section G)
CORDIS DE MEXICO
circuito int nte 1820
juarez 32575
MX   32575
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014
MDR Report Key6730511
MDR Text Key80646609
Report Number9616099-2017-01260
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032036556
UDI-Public20705032036556
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 08/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Catalogue NumberPC1040RXC
Device Lot Number17666761
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/17/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/26/2017
Initial Date FDA Received07/20/2017
Supplement Dates Manufacturer Received07/17/2017
Supplement Dates FDA Received08/07/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/10/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-